Current Practice in Italy of VF Testing at Implant: What Do We Know and Where Do We Go From Here?
The standardized requirements for cardioverter defibrillator (ICD) implantation, with or without cardiac resynchronization therapy (CRT), include defibrillation testing (DT), which consists of the induction and termination of ventricular fibrillation (VF). This procedure has been followed from the early days of ICD therapy in order to assess the reliability of an implanted ICD device and to measure the defibrillation threshold. Effective DT is considered mandatory in accordance with the rules of good clinical practice.
KeywordsVentricular Fibrillation Cardiac Resynchronization Therapy Systolic Heart Failure Induction Test Cardiac Resynchronization Therapy Device
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Alter P, Waldhans S, Plachta E et al (2005) Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing Clin Electrophysiol 28:926–932PubMedCrossRefGoogle Scholar
Russo AM, Sauer W, Gerstenfeld EP et al (2005) Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2:456–461PubMedCrossRefGoogle Scholar
Pires LA, Johnson KM (2006) Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 17:140–145PubMedCrossRefGoogle Scholar
Strickberger SA, Klein GJ (2004) Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 44:88–91PubMedCrossRefGoogle Scholar
Ezekowitz JA, Armstrong PW, McAlister FA (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138:445–452PubMedGoogle Scholar
Sweeney MO, Schoenfeld MH, Cannom DS (2005) Rules of evidence: CMS and primary prevention of sudden cardiac death in systolic heart failure. Pacing Clin Electrophysiol 28:81–88PubMedCrossRefGoogle Scholar
Proclemer A, Ghidina M, Cicuttini G et al (2006) Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy. A survey of the national activity during the years 2001–2004. Pacing Clin Electrophysiol 29(Suppl 2):S20–S28PubMedCrossRefGoogle Scholar
Greenberg SM, Epstein AE, Deering T et al (2007) Differences in international ICD implantation rates: comparison of US and Italian practice. Pacing Clin Electrophysiol (in press)Google Scholar
Tokano T, Bach D, Chang J et al (1998) Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 9:791–797PubMedCrossRefGoogle Scholar
Gilbert TB, Gold MR, Shorofsky SR et al (2002) Cardiovascular responses to repetitive defibrillation during implantable cardioverter-defibrillator testing. J Cardiothorac Vasc Anesth 16:180–185PubMedCrossRefGoogle Scholar
Gasparini M, Galimberti P, Regoli F et al (2005) Delayed defibrillation testing in patients implanted with biventricular ICD (CRT-D): a reliable and safe approach. J Cardiovasc Electrophysiol 16:1279–1283PubMedCrossRefGoogle Scholar
Fiek M, Zieg B, Matis T et al (2006) Analysis of the cause of death of ICD patients during long-term follow-up. Herzschrittmacherther Elektrophysiol 17:6–12PubMedCrossRefGoogle Scholar
Mitchell LB, Pineda EA, Titus JL et al (2002) Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. J Am Coll Cardiol 39:1323–1328PubMedCrossRefGoogle Scholar
Neuzner (2005) Is DFT testing still mandatory? Herz 30:601–606PubMedCrossRefGoogle Scholar
Favale S (2005) Test di defibrillazione durante l’impianto di defibrillatore automatico: è a ncora necessario? G Ital Aritmol Cardiostim 2:73–77Google Scholar
© Springer-Verlag Italia 2007